Synergistic Effects of Antimicrobial Peptides and Antibiotics against Clostridium difficile

Effects of ciprofloxacin on the expression and production of exotoxins by Clostridium difficile

(2013) M. J. Aldape et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Clostridium difficile clinical isolates exhibit variable susceptibility and proteome alterations upon exposure to mammalian cationic antimicrobial peptides

(2012) Rebecca McQuade et al.   ANAEROBE

Prophage Carriage and Diversity within Clinically Relevant Strains of Clostridium difficile

(2012) Jinyu Shan et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Current State of Clostridium difficile Treatment Options

(2012) A. A. Venugopal et al.   CLINICAL INFECTIOUS DISEASES

Paneth cell α-defensins in enteric innate immunity

(2011) André Joseph Ouellette   CELLULAR AND MOLECULAR LIFE SCIENCES

Prophage-Stimulated Toxin Production in Clostridium difficile NAP1/027 Lysogens

(2011) O. Sekulovic et al.   JOURNAL OF BACTERIOLOGY

Reduction of disulphide bonds unmasks potent antimicrobial activity of human β-defensin 1

(2011) Bjoern O. Schroeder et al.   NATURE

Fidaxomicin versus Vancomycin forClostridium difficileInfection

(2011) Thomas J. Louie et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antibacterial activity of human defensins on anaerobic intestinal bacterial species: a major role of HBD-3

(2009) Sabine Nuding et al.   MICROBES AND INFECTION

The role of the multifunctional peptide LL-37 in host defense

(2008) Ylva Kai-Larsen   Frontiers in Bioscience-Landmark

Human α-Defensins Inhibit Clostridium difficile Toxin B

(2008) Torsten Giesemann et al.   GASTROENTEROLOGY